Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Mulé SJ[au]:

Search results

Items: 1 to 50 of 106

1.
2.
4.
5.

Active and realistic passive marijuana exposure tested by three immunoassays and GC/MS in urine.

Mulé SJ, Lomax P, Gross SJ.

J Anal Toxicol. 1988 May-Jun;12(3):113-6.

PMID:
3386204
7.

Significance of urine assay sensitivity in marijuana detection.

Mulé SJ, Gross SJ.

Clin Chem. 1987 Apr;33(4):613. No abstract available.

PMID:
3829403
8.

A quick, qualitative assay for alcohol in urine.

Verebey K, Mulé SJ.

J Anal Toxicol. 1986 Jul-Aug;10(4):167-8. No abstract available.

PMID:
3747460
9.

Determination of 6-beta-naltrexol and naltrexone by bonded-phase adsorption thin-layer chromatography.

Verebey K, Alarazi J, Lehrer M, Mulé SJ.

J Chromatogr. 1986 May 28;378(1):261-6. No abstract available.

PMID:
3733981
10.

One hundred EMIT positive cannabinoid urine samples confirmed by BPA/TLC, RIA, and GC/MS.

Verebey K, Mulé SJ, Alrazi J, Lehrer M.

J Anal Toxicol. 1986 Mar-Apr;10(2):79-80. No abstract available.

PMID:
3517489
11.

Naltrexone (Trexan): a review of hepatotoxicity issues.

Verebey KG, Mulé SJ.

NIDA Res Monogr. 1986;67:73-81. No abstract available.

PMID:
3092100
12.
13.

A rapid, quantitative GLC method for the simultaneous determination of nicotine and cotinine.

Verebey KG, DePace A, Mulé SJ, Kanzler M, Jaffe JH.

J Anal Toxicol. 1982 Nov-Dec;6(6):294-6.

PMID:
7162139
14.

Confirmation of EMIT benzodiazepine assay with GLC/NPD.

Verebey K, Jukofsky D, Mulé SJ.

J Anal Toxicol. 1982 Nov-Dec;6(6):305-8.

PMID:
6761510
15.

Estimation of phencyclidine in leafy mixtures and in vapor phase after smoking.

Kogan MJ, Verebey K, Mule SJ.

Subst Alcohol Actions Misuse. 1982;3(1-2):117-9.

PMID:
7135155
16.

Analytical approach: the status of the art.

Mulè SJ.

Ann Ist Super Sanita. 1982;18(4):765-7. No abstract available.

PMID:
6765294
17.

Quality control program in the USA.

Mulè SJ.

Ann Ist Super Sanita. 1982;18(4):705-11. No abstract available.

PMID:
6089639
18.

Simultaneous determination of nicotine and cotinine in human plasma by nitrogen detection gas-liquid chromatography.

Kogan MJ, Verebey K, Jaffee JH, Mulé SJ.

J Forensic Sci. 1981 Jan;26(1):6-11.

PMID:
7205189
19.

Phencyclidine-induced stereotype in rats: effects of methadone, apomorphine, and naloxone.

Verebey K, Kogan MJ, Mulè SJ.

Psychopharmacology (Berl). 1981;75(1):44-7.

PMID:
6795658
20.

Evaluation of the TRI 'dipstick' test for the detection of drugs of abuse in urine.

Jukofsky D, Kramer A, Mulé SJ.

J Anal Toxicol. 1981 Jan-Feb;5(1):14-9.

PMID:
6783782
21.

Qualitative differentiation between cocaine, lidocaine and cocaine-lidocaine mixtures ("rock-cocaine") using thin-layer chromatography.

Jukofsky D, Verebey K, Mulé SJ.

J Chromatogr. 1980 Oct 24;198(4):534-5. No abstract available.

PMID:
7440689
22.

Pharmacokinetics and metabolism of l-alpha-[O,O'-3H2]-acetyl normethadol (nor-LAAM), the active metabolite of LAAM, in acutely and chronically treated rhesus monkeys.

Misra AL, Bartolomeo JG, Bloch R, Mulé SJ, Bates TR.

J Pharmacol Exp Ther. 1980 Sep;214(3):599-607. No abstract available.

PMID:
6772759
24.

Increased serum methadone levels in humans during naloxone-precipitated withdrawal [proceedings].

Resnick RB, Washton A, Verebey K, Mule SJ.

Psychopharmacol Bull. 1979 Apr;15(2):42-4. No abstract available.

PMID:
432371
25.
26.

Radioimmunoassay of methaqualone in human urine compared with chromatographic methods.

Mulé SJ, Kogan M, Jukofsky D.

Clin Chem. 1978 Sep;24(9):1473-6.

27.

Detection of methaqualone in human urine by radioimmunoassay and gas-liquid chromatography after a therapeutic dose.

Kogan KJ, Jukofsky D, Verebey K, Mulé SJ.

Clin Chem. 1978 Aug;24(8):1425-6. No abstract available.

PMID:
679471
28.

The effect of ethanol on the metabolism of chronically-administered l-alpha-acetylmethadol (LAAM) in the rhesus monkey.

Casella GA, Deneau GA, Mule SJ.

Res Commun Chem Pathol Pharmacol. 1978 Aug;21(2):351-4.

PMID:
99782
29.

Physiological disposition and biotransformation of l-alpha-[2-3H]acetylmethadol (LAAM) in acutely and chronically treated monkeys.

Misra AL, Mulé SJ, Bloch R, Bates TR.

J Pharmacol Exp Ther. 1978 Aug;206(2):475-91. No abstract available.

PMID:
98628
30.

Comparative effects of cocaine and pseudococaine on EEG activities, cardiorespiratory functions, and self-administration behavior in the rhesus monkey.

Matsuzaki M, Spingler PJ, Whitlock EG, Misra AL, Mulé SJ.

Psychopharmacology (Berl). 1978 Apr 14;57(1):13-20.

PMID:
96463
31.

Pharmacology of l-alpha-acetylmethadol (LAAM) in subhuman primates.

Mulé SJ, Misra AL.

Ann N Y Acad Sci. 1978;311:199-213. No abstract available.

PMID:
105659
32.

Quantitative determination of benzoylecgonine and cocaine in human biofluids by gas-liquid chromatography.

Kogan MJ, Verebey KG, DePace AC, Resnick RB, Mulé SJ.

Anal Chem. 1977 Nov;49(13):1965-9. No abstract available.

PMID:
907157
33.
34.

Disposition and metabolism of [3H] cocaine in acutely and chronically treated monkeys.

Misra AL, Giri VV, Patel MN, Alluri VR, Mulé SJ.

Drug Alcohol Depend. 1977 Jul;2(4):261-72. No abstract available.

PMID:
560292
35.

Evaluation of the radioimmunoassay for benzoylecgonine (a cocaine metabolite) in human urine.

Mulé SJ, Jukofsky D, Kogan M, De Pace A, Verebey K.

Clin Chem. 1977 May;23(5):796-801.

36.
37.

Intracellular disposition of (3H)-cocaine, (3H)-norcocaine, (3H)-benzoylecgonine and (3H)-benzoylnorecgonine in the brain of rats.

Mule SJ, Casella GA, Misra AL.

Life Sci. 1976 Nov 15;19(10):1585-96. No abstract available.

PMID:
994703
38.

Disposition and metabolism of [3H]cocaine in acutely and chronically treated dogs.

Misra AL, Patel MN, Alluri VR, Mulé SJ, Nayak PK.

Xenobiotica. 1976 Sep;6(9):537-52.

PMID:
983124
39.

Naltrexone: disposition, metabolism, and effects after acute and chronic dosing.

Verebey K, Volavka J, Mulé SJ, Resnick RB.

Clin Pharmacol Ther. 1976 Sep;20(3):315-28.

PMID:
954353
40.

Cocaine: tolerance to its convulsant and cardiorespiratory stimulating effects in the monkey.

Matsuzaki M, Spingler PJ, Misra AL, Mule SJ.

Life Sci. 1976 Jul 15;19(2):193-203. No abstract available.

PMID:
822244
41.

Disposition of (15,16-3H)naltrexone in the central nervous system of the rat.

Misra AL, Bloch R, Vardy J, Mulé SJ, Verebely K.

Drug Metab Dispos. 1976 May-Jun;4(3):276-80.

PMID:
6233
42.

Quantitative determination of naltrexone and beta-naltrexol in human plasma using electron detection.

Verebey K, Kogan MJ, DePace A, Mulé SJ.

J Chromatogr. 1976 Apr 7;118(3):331-5.

PMID:
1254668
43.

Disposition of (3H) benzoylnorecgonine (cocaine metabolite) in the rat.

Misra AL, Giri VV, Patel MN, Alluri VR, Pontani RB, Mule SJ.

Res Commun Chem Pathol Pharmacol. 1976 Apr;13(4):579-84.

PMID:
1265338
44.

Pharmacokinetics and metabolism of (-)-alpha-[2-3H]acetylmethadol (LAAM) in the monkey: evidence for a new metabolite.

Misra AL, Vardy J, Bloch R, Mulé SJ, Deneau GA.

J Pharm Pharmacol. 1976 Apr;28(4):316-8. No abstract available.

PMID:
6726
45.

Physiological disposition and biotransformation of (3H) cocaine in acutely and chronically treated rats.

Nayak PK, Misra AL, Mulé SJ.

J Pharmacol Exp Ther. 1976 Mar;196(3):556-69.

PMID:
1263111
46.

Physiological disposition and biotransformation of [allyl-1', 3' - 14C naloxone in the rat and some comparative observations on nalorphine.

Misra AL, Pontani RB, Vadlamani NL, Mulé SJ.

J Pharmacol Exp Ther. 1976 Feb;196(2):257-68.

PMID:
1255476
48.

Methodological problems in drug interactions.

Mulé SJ.

Ann N Y Acad Sci. 1976;281:106-17. Review. No abstract available.

PMID:
798518
49.

The specificity of binding of the narcotic agonist etorphine in synaptic membranes of rat brain in vivo.

Mulé SJ, Casella G, Clouet DH.

Psychopharmacologia. 1975 Oct 31;44(2):125-9.

PMID:
707
50.

Estimation and disposition of [3H]benzoylecgonine and pharmacological activity of some cocaine metabolites.

Misra AL, Nayak PK, Bloch R, Mulé SJ.

J Pharm Pharmacol. 1975 Oct;27(10):784-6. No abstract available.

PMID:
241797

Supplemental Content

Support Center